Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 50,875 shares at $134.99 ($7.0M) on 2012-07-30, disclosed to the SEC on 2012-07-31.
Scheduled sale ($7.0M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.39 | 1,711 | $235K | 3.4% |
| 2 | $137.39 | 1,994 | $274K | 3.9% |
| 3 | $137.39 | 2,980 | $409K | 5.9% |
| 4 | $137.39 | 4,839 | $665K | 9.6% |
| 5 | $137.39 | 5,661 | $778K | 11.2% |
| 6 | $137.39 | 9,856 |
| $1.4M |
| 19.5% |
| 7 | $134.99 | 67 | $9K | 0.1% |
| 8 | $135.49 | 14,833 | $2.0M | 28.9% |
| 9 | $136.26 | 6,600 | $899K | 12.9% |
| 10 | $137.58 | 2,334 | $321K | 4.6% |
| Total | $136.70 avg | 50,875 | $7.0M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |